LK-75

N/A

Report date: 2024/03/19 15:35:33
NME

Base Information

Drug NameLK-75
Drug Alias NameLK-75
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCollege of Pharmaceutical Sciences Zhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesCollege of Pharmaceutical Sciences Zhejiang University
Inactive CompaniesN/A
Active IndicationsMycobacterium Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A